D. Medical Signs an Additional U.S. Distribution Agreement for Spring Universal Infusion Sets

D. Medical Industries Ltd.

announced today that its indirect subsidiary, Spring Health Solutions Inc. ("Spring Health"), has signed a non-exclusive agreement with an undisclosed party for the distribution of its Spring™ Universal Infusion Sets in the United States. The agreement has an initial term of two years, and will thereafter be automatically renewed for one-year periods, unless terminated by the parties. In addition, each party may terminate the agreement upon three months prior written notice to the other party. "The new distribution agreement, signed in the U.S., will allow us to bring the Spring Universal novel technology to even more people with diabetes across the U.S. It is also aligned with our strategy of focusing on partnering with high quality value creators," said Efri Argaman, D. Medical's Chief Executive Officer.